Score Of Foreign Drug Makers Face Lower China Price Caps As Of May 1
This article was originally published in PharmAsia News
Executive Summary
A score of foreign drug makers face a reduction in the prices they charge for digestive-related drugs in China as a result of a scheduled May 1 lowering of price caps by an average 17%.